Programme Thesis
This NIH BRAIN Initiative U01 program funds basic experimental studies involving invasive neural recording and/or stimulating technologies in human participants, aiming to advance understanding of human brain function and dysfunction. It exists to support high-risk, high-reward research that leverages direct neural interfaces to uncover fundamental neural mechanisms, with a strong emphasis on safety, ethical conduct, and translational potential.
Selection Criteria
Eligibility: U.S. institutions only (foreign components allowed but applicant must be at a U.S. institution); applicant must be an eligible PI at a domestic organization. Scoring rubric (1-9 scale): Significance (30%), Investigator(s) (20%), Innovation (15%), Approach (30%), Environment (5%). Reviewer priorities: strong preliminary data, clear hypothesis-driven design, rigorous statistical plan, demonstrated expertise in human invasive recordings/stimulation, robust safety and ethical oversight, feasibility of recruitment and data collection, and potential to transform understanding of neural circuits.
Past Winners / Cohort Profiles
Past winners are typically established neuroscientists or clinical researchers at U.S. academic medical centers or research universities (e.g., Stanford, UCSF, Harvard, University of Washington). Archetypes: (1) a PI with a track record of human intracranial EEG or deep brain stimulation studies, (2) a team combining clinical neurology/neurosurgery with computational neuroscience, (3) projects targeting specific brain disorders (epilepsy, Parkinson's, psychiatric conditions) using closed-loop or stimulation paradigms. Named examples not available on the page but common in the BRAIN Initiative portfolio: R. Mark Richardson (U. Pittsburgh), Edward Chang (UCSF), Kareem Zaghloul (NIH).
Ideal Candidate Fingerprint
A mid-to-senior career neuroscientist or neurologist at a U.S. research university with a proven record of human invasive neural recording/stimulation studies, strong preliminary data from pilot experiments, and a multidisciplinary team including neurosurgeons, engineers, and statisticians. The ideal applicant has a clear, mechanistic hypothesis about human neural circuit function, a rigorous experimental design with power analysis, and a well-articulated plan for data sharing and dissemination.
Recommended Framing
Eniola should frame his CCT model as a computational framework that can be tested using invasive neural recording/stimulation in human addiction patients, leveraging his collaborations with Kent Berridge and Samuel Gershman to demonstrate theoretical grounding and access to expertise. He must emphasize his unique computational pharmacology perspective and the potential of CCT to guide closed-loop neuromodulation strategies, but he must also address the critical eligibility hurdle by proposing a partnership with a U.S. institution (e.g., University of Michigan or Harvard) where he would serve as a co-investigator or consultant, not as the lead PI. Highlighting his provisional patent and Bayesian validation adds credibility, but the application must clearly show how his work fits within a U.S.-led team with access to human subjects and invasive technologies.
Watch Out
Primary red flag: Eniola is an independent researcher in Nigeria with no U.S. institutional affiliation; this U01 requires the PI to be at a U.S. institution. He is not eligible as a lead applicant. Additionally, he has no prior experience with human invasive neural recording/stimulation, which is a core requirement. His age and career stage (pre-PhD) are far below the typical PI profile for this mechanism. The program is for basic experimental studies with humans, requiring IRB approval and clinical infrastructure he lacks.